Always DYOR and understand the dynamics of these OTC stocks (known for pump & dump) but the fundamentals here are what will ultimately drive Sunshine Biopharma to return to it's formerly glorious highs but for now, it's relegated to the fractional levels that we see. On it's face, it looks like a no-brainer . . company shedding debt, increasing earnings (still no...
The chart speaks for itself: ARDS is in a massive bullish divergence at all time low levels from which can explode anytime soon! Recently, analyst Vernon Bernardino from H.C. Wainwright, who reiterated a buy rating and $19 price target on ARDS , told investors that Aridis Pharmaceuticals Inc 's monoclonal Covid-19 Antibody Cocktail is potentially First-in-Class...
New Data suggest COVAXIN (BBV152) may provide protection against current and future variants! data from a Phase 3 trial that included nearly 25,800 participants: 77.8% overall efficacy, 93.4% efficacy against severe illness and 65.2% efficacy against the Delta variant. 52 Week Range 0.28 - 18.77 My price target is the 10.30usd resistance.
We cautioned readers yesterday to exercise caution with stocks and this advice was warranted, as stocks have dipped further into negative territory. Global stocks have pushed lower with news of the first case of the Omicron strain of the Coronavirus was confirmed in the United States. We have broken through what appeared to be strong support at 4580, then 4564,...
^ $BNTX will announce if its possible to revise their current vaccine to accommodate the new strain in 2 weeks and could redesign its vaccine within 6 weeks, with an aim to distribute it within 100 days. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the...
Hi guys, I think Moderna will go up again and get a trend change up. Today Moderna breaks out of the trenchannel and the rsi has also potential for going up. If the chart goes over the EMAs than it get also from them supported and have a good chance to go up again. what you guys think?
Tomorrow Chembio Diagnostics CEMI will Report Second Quarter 2021 Financial Results. Things to consider: $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil $4 million purchase order from the Partnership for Supply Chain Management (PFSCM), for the purchase of HIV 1/2 STAT-PAK Assay for shipment to Ethiopia those are just some...
On 4/20/2021 HC Wainwright brokerage Reiterated Rating to Buy and a Price Target of $16.00 for NRBO But how come? What`s the catalyst? Why NeuroBo Pharmaceuticals was up 40% yesterday? Richard J. Kang, CEO: "Throughout the first quarter of 2021, we continued to make progress advancing the 60-patient Phase 2/3 clinical trial of our lead drug candidate, ANA001,...
Since Covid-19 is here to stay with us with its variants and the vaccines don`t offer lifetime protection, this means that there is room for other companies to develop a better vaccine to address the problem. And the gains in vaccines stock are quite similar to cryptocurrencies year over year. From all time low to all time high, BNTX made 19X, MRNA 24X and NVAX...
On 6/15/2021 Cantor Fitzgerald brokerage Boosted the Price Target from Reduce to Overweight $217.00 to $272.00 On 5/18/2021 JPMorgan Chase & Co. brokerage Reiterated Rating from Overweight to Neutral $285.00 to $161.00 On 5/12/2021 B. Riley brokerage Lowered the Price Target from $365.00 to $286.00 On 5/12/2021 HC Wainwright brokerage Lowered the...
VXA-CoV2-1, Vaxart's experimental treatment for Covid-19 is unique in that it's a pill, not an injection. A pill would certainly be easier from a distribution and administration standpoint but also to get higher vaccination rates. On May 3, Vaxart's treatment showed demonstrable CD8 T-cell responses, but didn't produce high levels of neutralizing antibodies...
BVB is undervalued anyway and hasn't fully bounced back from the corona virus hit yet - great upward potential 🏆 As one of the few european football stocks out there, Borussia Dortmund is a rare opportunity from both fundamental perspective and in regards to the corona pandemic, which naturally damaged this stock substantially. But it's time to bounce back! With...
The COVID-19 pandemic is holding the world, the economy and our health in a tight grip. So far Biontech/Pfizer have been successful with their vaccination, but as the virus mutates, it is unclear how effective the vaccination is. Many COVID-19 infected patients have to be hospitalized with a need for mechanical ventilation and that is where Humanigen plays a major...
DISCLAIMER 1) You should consider your own Risk:Reward ratio and do proper lot sizing according to your margin and leverage level. 2 ) Not every idea is a valid trade. Some are pending orders. 3) This analysis is just a trading idea, not a trading signal for you. 4) My own trend direction estimation, entry point, stop loss and take profit levels are shown on...
DISCLAIMER 1) You should consider your own Risk:Reward ratio and do proper lot sizing according to your margin and leverage level. 2 ) Not every idea is a valid trade. Some are pending orders. 3) This analysis is just a trading idea, not a trading signal for you. 4) My own trend direction estimation, entry point, stop loss and take profit levels are shown on...
DISCLAIMER 1) You should consider your own Risk:Reward ratio and do proper lot sizing according to your margin and leverage level. 2 ) Not every idea is a valid trade. Some are pending orders. 3) This analysis is just a trading idea, not a trading signal for you. 4) My own trend direction estimation, entry point, stop loss and take profit levels are shown on...
Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical Cell Culture Studies Performed in Preparation of FDA Pre-IND Application $NNVC reported yesterday on the strong pan-coronavirus effectiveness of its two COVID-19 clinical drug candidates for which the Company is preparing a pre-IND application. NV-CoV-2...
New Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery in Mild-to-Moderate COVID-19 Patients New Phase 3 study results show added nutritional protocol reduces recovery time in mild-to-moderate COVID-19 patients The addition of the nutritional protocol, or combined metabolic activators (CMA), to the Turkish...